tiprankstipranks
uniQure N.V. (MX:QUREN)
:QUREN
Mexico Market
QUREN
uniQure
RESEARCH TOOLSreports

uniQure (QUREN) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

QUREN Analyst Ratings

Strong Buy
12Ratings
Strong Buy
11 Buy
1 Hold
0 Sell
Based on 12 analysts giving stock ratings to
uniQure
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

QUREN Stock 12 Month Forecast

Average Price Target

$1,137.34
▲(42.35% Upside)
Based on 12 Wall Street analysts offering 12 month price targets for uniQure in the last 3 months. The average price target is $1,137.34 with a high forecast of $1,351.97 and a low forecast of $777.38. The average price target represents a 42.35% change from the last price of $799.00.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"264":"$264","536":"$536","808":"$808","1080":"$1,080","1352":"$1,352"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1351.9679584,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.35K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1137.343045004,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$1.14K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":777.38157608,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$777.38</span>\n  </div></div>","useHTML":true}}],"tickPositions":[264,536,808,1080,1352],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,799,841.5359968,884.0719936,926.6079904000001,969.1439872000001,1011.6799840000001,1054.2159808000001,1096.7519776,1139.2879744000002,1181.8239712,1224.3599680000002,1266.8959648,1309.4319616,{"y":1351.9679584,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,799,825.0263880772308,851.0527761544615,877.0791642316923,903.105552308923,929.1319403861538,955.1583284633846,981.1847165406155,1007.2111046178461,1033.237492695077,1059.2638807723076,1085.2902688495385,1111.3166569267692,{"y":1137.343045004,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,799,797.3370443138461,795.6740886276923,794.0111329415384,792.3481772553846,790.6852215692307,789.0222658830769,787.359310196923,785.6963545107692,784.0333988246153,782.3704431384615,780.7074874523076,779.0445317661538,{"y":777.38157608,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":265,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1065.69,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1065.69,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1065.69,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":373.55,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":401,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":401,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":401,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":401,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":479.55,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":795.45,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":795.45,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":799,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$1,352Average Price Target$1,137Lowest Price Target$777.38
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on MX:QUREN
Yanan Zhu
Wells Fargo
Wells Fargo
$1,267.47
Buy
58.63%
Upside
Reiterated
09/03/26
Analysts Are Bullish on These Healthcare Stocks: Biogen (BIIB), uniQure (QURE)
TD Cowen Analyst forecast on MX:QUREN
Joseph Thome
TD Cowen
TD Cowen
―
Buy
―
Reiterated
09/02/26
Analysts' Top Healthcare Picks: uniQure (QURE), Alumis Inc. (ALMS)
William Blair Analyst forecast on MX:QUREN
Sami Corwin
William Blair
William Blair
$1,233.67
Buy
54.40%
Upside
Initiated
09/02/26
Analysts Offer Insights on Healthcare Companies: McKesson (NYSE: MCK), uniQure (NASDAQ: QURE) and Establishment Labs Holdings (NASDAQ: ESTA)
Stifel Nicolaus Analyst forecast on MX:QUREN
Paul Matteis
Stifel Nicolaus
Stifel Nicolaus
$1,199.87
Buy
50.17%
Upside
Reiterated
08/13/26
Stifel Nicolaus Sticks to Its Buy Rating for uniQure (QURE)
H.C. Wainwright Analyst forecast on MX:QUREN
Patrick Trucchio
H.C. Wainwright
H.C. Wainwright
$1,351.97
Buy
69.21%
Upside
Reiterated
07/30/26
Analysts Are Bullish on Top Healthcare Stocks: Annexon Biosciences (ANNX), uniQure (QURE)
Barclays Analyst forecast on MX:QUREN
Eliana Merle
Barclays
Barclays
$1,098.47→$1,013.98
Buy
26.91%
Upside
Reiterated
07/30/26
Barclays Keeps Their Buy Rating on uniQure (QURE)
Wolfe Research Analyst forecast on MX:QUREN
Rudy Li
Wolfe Research
Wolfe Research
$1,098.47
Buy
37.48%
Upside
Upgraded
07/29/26
uniQure upgraded to Outperform from Peer Perform at Wolfe ResearchuniQure upgraded to Outperform from Peer Perform at Wolfe Research
Goldman Sachs Analyst forecast on MX:QUREN
Salveen Richter
Goldman Sachs
Goldman Sachs
$777.38
Hold
-2.71%
Downside
Reiterated
07/29/26
Analysts Offer Insights on Healthcare Companies: Teladoc (NYSE: TDOC), Fortrea Holdings Inc. (NASDAQ: FTRE) and uniQure (NASDAQ: QURE)
Mizuho Securities Analyst forecast on MX:QUREN
Uy Ear
Mizuho Securities
Mizuho Securities
$1,149.17
Buy
43.83%
Upside
Reiterated
07/29/26
Analysts Are Bullish on Top Healthcare Stocks: AbCellera Biologics (ABCL), uniQure (QURE)
RBC Capital Analyst forecast on MX:QUREN
Luca Issi
RBC Capital
RBC Capital
$1,098.47
Buy
37.48%
Upside
Reiterated
07/29/26
RBC Capital Sticks to Their Buy Rating for uniQure (QURE)
Leerink Partners Analyst forecast on MX:QUREN
Joseph Schwartz
Leerink Partners
Leerink Partners
$608.39→$1,182.97
Buy
48.06%
Upside
Reiterated
06/17/26
Analysts Are Bullish on These Healthcare Stocks: uniQure (QURE), Biohaven Ltd. (BHVN)
Cantor Fitzgerald Analyst forecast on MX:QUREN
Kristen Kluska
Cantor Fitzgerald
Cantor Fitzgerald
―
Buy
―
Upgraded
06/17/26
uniQure upgraded to Overweight from Neutral at Cantor FitzgeralduniQure upgraded to Overweight from Neutral at Cantor Fitzgerald
Guggenheim Analyst forecast on MX:QUREN
Unknown Analyst
Guggenheim
Not Ranked
Guggenheim
$1,605.46
Buy
100.93%
Upside
Reiterated
05/05/26
Guggenheim Sticks to Their Buy Rating for uniQure (QURE)
Chardan Capital Analyst forecast on MX:QUREN
Daniil Gataulin
Chardan Capital
Chardan Capital
$625.29
Buy
-21.74%
Downside
Reiterated
05/05/26
Chardan Capital Remains a Buy on uniQure (QURE)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on MX:QUREN
Yanan Zhu
Wells Fargo
Wells Fargo
$1,267.47
Buy
58.63%
Upside
Reiterated
09/03/26
Analysts Are Bullish on These Healthcare Stocks: Biogen (BIIB), uniQure (QURE)
TD Cowen Analyst forecast on MX:QUREN
Joseph Thome
TD Cowen
TD Cowen
―
Buy
―
Reiterated
09/02/26
Analysts' Top Healthcare Picks: uniQure (QURE), Alumis Inc. (ALMS)
William Blair Analyst forecast on MX:QUREN
Sami Corwin
William Blair
William Blair
$1,233.67
Buy
54.40%
Upside
Initiated
09/02/26
Analysts Offer Insights on Healthcare Companies: McKesson (NYSE: MCK), uniQure (NASDAQ: QURE) and Establishment Labs Holdings (NASDAQ: ESTA)
Stifel Nicolaus Analyst forecast on MX:QUREN
Paul Matteis
Stifel Nicolaus
Stifel Nicolaus
$1,199.87
Buy
50.17%
Upside
Reiterated
08/13/26
Stifel Nicolaus Sticks to Its Buy Rating for uniQure (QURE)
H.C. Wainwright Analyst forecast on MX:QUREN
Patrick Trucchio
H.C. Wainwright
H.C. Wainwright
$1,351.97
Buy
69.21%
Upside
Reiterated
07/30/26
Analysts Are Bullish on Top Healthcare Stocks: Annexon Biosciences (ANNX), uniQure (QURE)
Barclays Analyst forecast on MX:QUREN
Eliana Merle
Barclays
Barclays
$1,098.47→$1,013.98
Buy
26.91%
Upside
Reiterated
07/30/26
Barclays Keeps Their Buy Rating on uniQure (QURE)
Wolfe Research Analyst forecast on MX:QUREN
Rudy Li
Wolfe Research
Wolfe Research
$1,098.47
Buy
37.48%
Upside
Upgraded
07/29/26
uniQure upgraded to Outperform from Peer Perform at Wolfe ResearchuniQure upgraded to Outperform from Peer Perform at Wolfe Research
Goldman Sachs Analyst forecast on MX:QUREN
Salveen Richter
Goldman Sachs
Goldman Sachs
$777.38
Hold
-2.71%
Downside
Reiterated
07/29/26
Analysts Offer Insights on Healthcare Companies: Teladoc (NYSE: TDOC), Fortrea Holdings Inc. (NASDAQ: FTRE) and uniQure (NASDAQ: QURE)
Mizuho Securities Analyst forecast on MX:QUREN
Uy Ear
Mizuho Securities
Mizuho Securities
$1,149.17
Buy
43.83%
Upside
Reiterated
07/29/26
Analysts Are Bullish on Top Healthcare Stocks: AbCellera Biologics (ABCL), uniQure (QURE)
RBC Capital Analyst forecast on MX:QUREN
Luca Issi
RBC Capital
RBC Capital
$1,098.47
Buy
37.48%
Upside
Reiterated
07/29/26
RBC Capital Sticks to Their Buy Rating for uniQure (QURE)
Leerink Partners Analyst forecast on MX:QUREN
Joseph Schwartz
Leerink Partners
Leerink Partners
$608.39→$1,182.97
Buy
48.06%
Upside
Reiterated
06/17/26
Analysts Are Bullish on These Healthcare Stocks: uniQure (QURE), Biohaven Ltd. (BHVN)
Cantor Fitzgerald Analyst forecast on MX:QUREN
Kristen Kluska
Cantor Fitzgerald
Cantor Fitzgerald
―
Buy
―
Upgraded
06/17/26
uniQure upgraded to Overweight from Neutral at Cantor FitzgeralduniQure upgraded to Overweight from Neutral at Cantor Fitzgerald
Guggenheim Analyst forecast on MX:QUREN
Unknown Analyst
Guggenheim
Not Ranked
Guggenheim
$1,605.46
Buy
100.93%
Upside
Reiterated
05/05/26
Guggenheim Sticks to Their Buy Rating for uniQure (QURE)
Chardan Capital Analyst forecast on MX:QUREN
Daniil Gataulin
Chardan Capital
Chardan Capital
$625.29
Buy
-21.74%
Downside
Reiterated
05/05/26
Chardan Capital Remains a Buy on uniQure (QURE)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ONCBeOne Medicines
DNLIDenali Therapeutics
SNDXSyndax Pharmaceuticals
ZYMEZymeworks
PTGXProtagonist Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering uniQure

3 Months
Joseph ThomeTD Cowen
Success Rate
14/24 ratings generated profit
58%
Average Return
+38.17%
Copying Joseph Thome's trades and holding each position for 3 Months would result in 58.33% of your transactions generating a profit, with an average return of +38.17% per trade.
1 Year
Patrick TrucchioH.C. Wainwright
Success Rate
17/20 ratings generated profit
85%
Average Return
+94.05%
Copying Patrick Trucchio's trades and holding each position for 1 Year would result in 85.00% of your transactions generating a profit, with an average return of +94.05% per trade.
2 Years
Patrick TrucchioH.C. Wainwright
Success Rate
18/20 ratings generated profit
90%
Average Return
+206.27%
Copying Patrick Trucchio's trades and holding each position for 2 Years would result in 90.00% of your transactions generating a profit, with an average return of +206.27% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

QUREN Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
15
10
11
7
7
Buy
4
10
12
10
3
Hold
10
4
5
3
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
29
24
28
20
12
In the current month, QUREN has received 10 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. QUREN average Analyst price target in the past 3 months is 1,137.34.
Each month's total comprises the sum of three months' worth of ratings.

QUREN Financial Forecast

QUREN Earnings Forecast

Next quarter’s earnings estimate for QUREN is -$15.59 with a range of -$20.60 to -$12.53. The previous quarter’s EPS was -$20.60. QUREN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year QUREN has Performed in-line its overall industry.
Next quarter’s earnings estimate for QUREN is -$15.59 with a range of -$20.60 to -$12.53. The previous quarter’s EPS was -$20.60. QUREN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year QUREN has Performed in-line its overall industry.

QUREN Sales Forecast

Next quarter’s sales forecast for QUREN is $104.55M with a range of $40.53M to $168.87M. The previous quarter’s sales results were $98.64M. QUREN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year QUREN has Performed in-line its overall industry.
Next quarter’s sales forecast for QUREN is $104.55M with a range of $40.53M to $168.87M. The previous quarter’s sales results were $98.64M. QUREN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year QUREN has Performed in-line its overall industry.

QUREN Stock Forecast FAQ

What is MX:QUREN’s average 12-month price target, according to analysts?
Based on analyst ratings, uniQure N.V.’s 12-month average price target is 1,137.34.
    What is MX:QUREN’s upside potential, based on the analysts’ average price target?
    uniQure N.V. has 42.35% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is uniQure N.V. a Buy, Sell or Hold?
          uniQure N.V. has a consensus rating of Strong Buy, which is based on 11 buy ratings, 1 hold ratings and 0 sell ratings.
            What is uniQure N.V.’s share price target?
            The average share price target for uniQure N.V. is 1,137.34. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is $1,351.97 ,and the lowest forecast is $777.38. The average share price target represents 42.35% Increase from the current price of $799.
              What do analysts say about uniQure N.V.?
              uniQure N.V.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
                How can I buy shares of uniQure N.V.?
                To buy shares of MX:QUREN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.